Icahn lawsuit calls for millions in damages, removal of Illumina board members

A newly unsealed lawsuit filed by activist investor Carl Icahn alleges that Illumina board members ignored antitrust regulators when buying Grail for $8 billion, failed to disclose key information about the deal and entrenched themselves as directors.

The lawsuit was filed in Delaware Chancery Court on Friday and seeks hundreds of millions of dollars in damages as well as the removal of board members.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

UKHSA agrees a deal to produce life-saving vaccines in the UK

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future influenza

September 26, 2023

Many Postpartum Check-Ups Omit Discussion of Mom’s Heart Health

For many new moms in recent years, the 4- to 6-week postpartum check-up still lacked cardiovascular health (CVH) counseling, according to nationally representative survey data.

July 26, 2023

Emergex and VIC to develop infectious disease therapies in the Gulf – Pharmaceutical Technology

VIC will have the Right of First Negotiation over new candidates proposed by Emergex for the territories covered under the agreement. Image Credit: TonelloPhotography /

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.